AL amyloidosis and progression to multiple myeloma with gain(1q)

British Journal of Haematology

Volumn 144, Issue 6, 2009, Pages 963-964

  Hoffman, James ^a   Jhanwar, Suresh ^a   Comenzo, Raymond L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Amyloidosis; Cytogenetics; Multiple myeloma

Indexed keywords

BORTEZOMIB; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; THALIDOMIDE;

ADULT; AMYLOIDOSIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CANCER GROWTH; CASE REPORT; CHROMOSOME 1Q; CLINICAL FEATURE; CONTINUOUS INFUSION; CYTOGENETICS; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LETTER; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; PRIORITY JOURNAL;

AMYLOIDOSIS; CHROMOSOMES, HUMAN, PAIR 1; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA;

EID: 60649083224     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07536.x     Document Type: Letter

References (10)

1. Arendt, B.K., Ramirez-Alvarado, M., Sikkink, L.A., Keats, J.J., Ahmann, G.J., Dispenzieri, A., Fonseca, R., Ketterling, R.P., Knudson, R.A., Mulvihill, E.M., Tschumper, R.C., Wu, X., Zeldenrust, S.R. Jelinek, D.F. (2008) Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2. Blood, 112, 1931 1941.
2. Bochtler, T., Hegenbart, U., Cremer, F.W., Heiss, C., Benner, A., Hose, D., Moos, M., Bila, J., Bartram, C.R., Ho, A.D., Goldschmidt, H., Jauch, A. Schonland, S.O. (2008) Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability. Blood, 111, 4700 4705.
3. Cohen, A.D., Zhou, P., Chou, J., Teruya-Feldstein, J., Reich, L., Hassoun, H., Levine, B., Filippa, D.A., Riedel, E., Kewalramani, T., Stubblefield, M.D., Fleisher, M., Nimer, S. Comenzo, R.L. (2007) Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial. British Journal of Haematology, 139, 224 233.
4. Gertz, M.A., Comenzo, R., Falk, R.H., Fermand, J.P., Hazenberg, B.P., Hawkins, P.N., Merlini, G., Moreau, P., Ronco, P., Sanchorawala, V., Sezer, O., Solomon, A. Grateau, G. (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. American Journal of Hematology, 79, 319 328.
5. International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. British Journal of Haematology, 121, 749 757.
6. Kyle, R.A., Gertz, M.A., Greipp, P.R., Witzig, T.E., Lust, J.A., Lacy, M.Q. Therneau, T.M. (1997) A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. New England Journal of Medicine, 336, 1202 1207.
7. Merlini, G. Stone, M.J. (2006) Dangerous small B-cell clones. Blood, 108, 2520 2530.
8. Rajkumar, S.V., Gertz, M.A. Kyle, R.A. (1998) Primary systemic amyloidosis with delayed progression to multiple myeloma. Cancer, 82, 1501 1505.
9. Sawyer, J.R., Tricot, G., Lukacs, J.L., Binz, R.L., Tian, E., Barlogie, B. Shaughnessy, Jr., J. (2005) Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1q. Genes, Chromosomes and Cancer, 42, 95 106.
10. Wechalekar, A.D., Hawkins, P.N. Gillmore, J.D. (2008) Perspectives in treatment of AL amyloidosis. British Journal of Haematology, 140, 365 377.